These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 28905237)
21. Targeting promiscuous heterodimerization overcomes innate resistance to ERBB2 dimerization inhibitors in breast cancer. Kennedy SP; Han JZR; Portman N; Nobis M; Hastings JF; Murphy KJ; Latham SL; Cadell AL; Miladinovic D; Marriott GR; O'Donnell YEI; Shearer RF; Williams JT; Munoz AG; Cox TR; Watkins DN; Saunders DN; Timpson P; Lim E; Kolch W; Croucher DR Breast Cancer Res; 2019 Mar; 21(1):43. PubMed ID: 30898150 [TBL] [Abstract][Full Text] [Related]
22. Identification of a region within the ErbB2/HER2 intracellular domain that is necessary for ligand-independent association. Penuel E; Akita RW; Sliwkowski MX J Biol Chem; 2002 Aug; 277(32):28468-73. PubMed ID: 12000754 [TBL] [Abstract][Full Text] [Related]
23. Signalling-competent truncated forms of ErbB2 in breast cancer cells: differential regulation by protein kinase C and phosphatidylinositol 3-kinase. Esparís-Ogando A; Díaz-Rodríguez E; Pandiella A Biochem J; 1999 Dec; 344 Pt 2(Pt 2):339-48. PubMed ID: 10567214 [TBL] [Abstract][Full Text] [Related]
25. A discrete three-amino acid segment (LVI) at the C-terminal end of kinase-impaired ErbB3 is required for transactivation of ErbB2. Schaefer G; Akita RW; Sliwkowski MX J Biol Chem; 1999 Jan; 274(2):859-66. PubMed ID: 9873025 [TBL] [Abstract][Full Text] [Related]
26. Crystallization and preliminary crystallographic studies of the single-chain variable fragment of antibody chA21 in complex with an N-terminal fragment of ErbB2. Liu Y; Zhou H; Zhu J; Gao Y; Niu L; Liu J; Teng M Acta Crystallogr Sect F Struct Biol Cryst Commun; 2009 Jul; 65(Pt 7):692-4. PubMed ID: 19574641 [TBL] [Abstract][Full Text] [Related]
28. NMR resonance assignments of caspase recruitment domain of RIP2 kinase. Lin Z Biomol NMR Assign; 2016 Oct; 10(2):241-4. PubMed ID: 26983939 [TBL] [Abstract][Full Text] [Related]
29. Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex. Franklin MC; Carey KD; Vajdos FF; Leahy DJ; de Vos AM; Sliwkowski MX Cancer Cell; 2004 Apr; 5(4):317-28. PubMed ID: 15093539 [TBL] [Abstract][Full Text] [Related]
30. 1H, 13C and 15N backbone resonance assignment of the intrinsically disordered region of the nuclear envelope protein emerin. Samson C; Herrada I; Celli F; Theillet FX; Zinn-Justin S Biomol NMR Assign; 2016 Apr; 10(1):179-82. PubMed ID: 26725056 [TBL] [Abstract][Full Text] [Related]
32. Downregulation of erbB3 abrogates erbB2-mediated tamoxifen resistance in breast cancer cells. Liu B; Ordonez-Ercan D; Fan Z; Edgerton SM; Yang X; Thor AD Int J Cancer; 2007 May; 120(9):1874-82. PubMed ID: 17266042 [TBL] [Abstract][Full Text] [Related]
33. Coexpression of Grb7 with epidermal growth factor receptor or Her2/erbB2 in human advanced esophageal carcinoma. Tanaka S; Mori M; Akiyoshi T; Tanaka Y; Mafune K; Wands JR; Sugimachi K Cancer Res; 1997 Jan; 57(1):28-31. PubMed ID: 8988034 [TBL] [Abstract][Full Text] [Related]
34. Combined Blockade of Activating Croessmann S; Formisano L; Kinch LN; Gonzalez-Ericsson PI; Sudhan DR; Nagy RJ; Mathew A; Bernicker EH; Cristofanilli M; He J; Cutler RE; Lalani AS; Miller VA; Lanman RB; Grishin NV; Arteaga CL Clin Cancer Res; 2019 Jan; 25(1):277-289. PubMed ID: 30314968 [TBL] [Abstract][Full Text] [Related]
35. Effects of oncogenic ErbB2 on G1 cell cycle regulators in breast tumour cells. Neve RM; Sutterlüty H; Pullen N; Lane HA; Daly JM; Krek W; Hynes NE Oncogene; 2000 Mar; 19(13):1647-56. PubMed ID: 10763821 [TBL] [Abstract][Full Text] [Related]
36. A dominant-negative N-terminal fragment of HER2 frequently expressed in breast cancers. Morancho B; Parra-Palau JL; Ibrahim YH; Bernadó Morales C; Peg V; Bech-Serra JJ; Pandiella A; Canals F; Baselga J; Rubio I; Arribas J Oncogene; 2013 Mar; 32(11):1452-9. PubMed ID: 22641219 [TBL] [Abstract][Full Text] [Related]
37. The single transmembrane domains of ErbB receptors self-associate in cell membranes. Mendrola JM; Berger MB; King MC; Lemmon MA J Biol Chem; 2002 Feb; 277(7):4704-12. PubMed ID: 11741943 [TBL] [Abstract][Full Text] [Related]
38. Identification of novel nuclear localization signal within the ErbB-2 protein. Chen QQ; Chen XY; Jiang YY; Liu J Cell Res; 2005 Jul; 15(7):504-10. PubMed ID: 16045813 [TBL] [Abstract][Full Text] [Related]
39. Dynamical Rearrangement of Human Epidermal Growth Factor Receptor 2 upon Antibody Binding: Effects on the Dimerization. Magalhães PR; Machuqueiro M; Almeida JG; Melo A; D S Cordeiro MN; Verde SC; Gümüş ZH; Moreira IS; D G Correia J; Melo R Biomolecules; 2019 Nov; 9(11):. PubMed ID: 31694351 [TBL] [Abstract][Full Text] [Related]
40. The ErbB/HER receptor protein-tyrosine kinases and cancer. Roskoski R Biochem Biophys Res Commun; 2004 Jun; 319(1):1-11. PubMed ID: 15158434 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]